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Abstract
Blue copper proteins (BCPs) comprise classic cases of Nature's profound control over the
electronic structures and chemical reactivity of transition metal ions. Early studies of BCPs
focused on their inner coordination spheres, that is, residues that directly coordinate Cu. Equally
important are the electronic and geometric perturbations to these ligands provided by the outer
coordination sphere. In this tribute to Hans Freeman, we review investigations that have advanced
the understanding of how inner-sphere and outer-sphere coordination affects biological Cu
properties.
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1. Introduction
Blue copper (Type 1 or T1) sites in proteins, which are found in a remarkable variety of
organisms ranging from bacteria to humans [1,2], have long fascinated chemists and
biologists. Single T1 Cu centers are encountered in small proteins such as plastocyanin and
azurin that shuttle electrons between various donors and acceptors. T1 Cu centers also are
found in larger proteins such as multicopper oxidases and nitrite reductases, where they
participate in intramolecular electron transfer (ET) reactions. The spectroscopic signatures
of T1 Cu are an intense (ε = 2,000-6,000 M–1 cm–1) ligand to metal charge transfer (LMCT)
absorption around 16,000 cm-1 (conferring a striking blue color) and a very small 63,65Cu
hyperfine splitting in their EPR spectra (A|| = 60-285 MHz). The latter feature in particular
distinguishes T1 from type 2 (T2) Cu centers, which have large 63,65Cu hyperfine splittings
(A|| ≥ 450 MHz). The spectroscopic properties of blue copper proteins have been discussed
in depth by Solomon and coworkers [3,4].
T1 Cu is one of Nature's ET workhorses. Its versatility is manifested by polypeptide-based
control over standard reduction potentials (E°); CuII/I potential tuning is a fascinating and
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vibrant realm of blue copper redox chemistry. CuII/I reduction potentials in BCPs span a
large window (E°’ = 0.18 to >1 V versus NHE (normal hydrogen electrode)), suiting these
proteins to redox with a wide variety of ET partners. Blue copper protein (BCP) reduction
potentials also are notably higher than the standard aqueous reduction potential, E°(CuII/I) =
0.161 V [5]. It has been recognized for over a century that its inner coordination sphere most
directly affects the redox properties of metal ions, and Lever has provided a clear illustration
of such inner-sphere control in his parameterization of some metal complex reduction
potentials [6]. Despite a wealth of data, an understanding of the effects of coordination on
many other reduction potentials remains elusive. For example, E° values have been reported
for a great many Cu coordination complexes [7-10], but a predictive model has yet to
emerge.
It also has been recognized for more than a century that ligands not directly coordinated to
metal ions can control reactivity [11]. Werner's definition [12] that the outer coordination
sphere is “a group coordinated directly to a ligand in the first sphere” is among the most
intuitive, but is perhaps too limiting. For example, steric clashes within the peptide matrix
can confer different geometries upon coordinated ligands. With this in mind, we propose a
broadening of the term “outer coordination sphere” to include those groups that in any way
influence the orientation and/or electronic properties of ligands directly coordinated to a
metal center. Also included in this definition are electrostatic contributions and
hydrophobicity or hyrophilicity effects that are particularly important in metalloprotein
redox chemistry.
Outer-sphere coordination is an important determinant of the reorganization energy for an
ET reaction. Nuclear reorganization of a metal center and coordinated ligands within a
peptide can cause a “ripple” effect of other structural changes throughout a protein. All of
these geometry changes contribute to the outer-sphere reorganization energy. Likewise,
outer-sphere coordination exerts control over transition metal reduction potentials (E°).
Hydrogen bonding (H-bonding) to or from coordinated residues, in particular, can tune the
electronic properties of the metal center. Furthermore, positioning charged or uncharged
hydrophilic residues can modulate potentials to favor more oxidized or more reduced metal
centers.
Well documented cases of outer-sphere effects in biological redox chemistry include
reduction potential tuning in Mn- and Fe-superoxide dismutases [13-15], oxygen binding in
globins [16] and oxygen binding, activation and heme redox tuning in peroxidases [17]. Of
special interest here is how inner- and outer-sphere coordination environments exert control
over the spectral and redox properties of BCPs. We will pay a great deal of attention to
Pseudomonas aeruginosa azurin, which within the present context is among the most studied
BCPs.
2. Historical Perspective
BCPs came on the scene in the 1950s and 1960s as their striking blue color led to their
observation and isolation from bacteria. These proteins had spectroscopic and chemical
properties that could not be reproduced in model complexes, and their structures were not
known. In the 1970s Hans Freeman turned his attention to structural BCP biology, and his
target was plastocyanin. After several false starts, he found that poplar leaves could provide
the right protein for crystal structure analysis. Many kilograms of poplar leaves were
harvested to obtain the plastocyanin for structural work. He and Mitchell Guss reported
preliminary structural data in 1977 [18], and in 1978 the 2.7 Å structure was published [19]
At the time, poplar plastocyanin was one of only 41 protein structures available in the
Protein Data Bank; there are now around 80,000 [20]. It would be hard to overstate the
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critical importance of this structure to bioinorganic chemistry, as until the 1990s, it was the
starting point for most, if not all, studies of BCPs and related model compounds.
3. Inner-Sphere Coordination
Blue copper sites are characterized by three strongly interacting ligands: one cysteine
thiolate and two histidine imidazoles. Additional weak interactions are frequently
encountered, typically involving an axial methionine thioether or glutamine amide. In the
azurins, a backbone carbonyl provides a second axial ligand. Many BCPs have been
characterized crystallographically: selected examples are shown in Figure 1. Multiple
structures with better than 1.5 Å resolution are available, facilitating detailed structural
analyses. The three strong ligands are arranged in a pseudo-trigonal manner; and the most
commonly encountered coordination modes are trigonal pyramidal, trigonal bipyramidal and
distorted tetrahedral. The CuII-S(Cys) bonds are remarkably short (2.1-2.3 Å) as a
consequence of high Cu-S π-covalency [3]. CuII-N(His) bond lengths are 1.9-2.1 Å and
typical of such interactions. When Met coordinates, the CuII-S(Met) bonds range from 2.6 to
3.2 Å. Where reduced (CuI) protein structures are available, the bonds are elongated by 0.1
Å or less and the structures of the oxidized and reduced proteins are nearly superimposable.
One notable exception is amicyanin, where one of the ligating histidines (His95) is not
bound to CuI. pH influences copper coordination in some wild-type (WT) proteins, but the
effect in other cases is small, as shown for P. aeruginosa azurin. Metrical parameters for
copper coordination in several representative blue proteins are set out in Table 1 [21-29].
Structures of apoproteins from azurin, plastocyanin and pseudoazurin are nearly identical
with those of the respective holoproteins. However, the active site must have some
conformational flexibility in order to bind copper in solution, as demonstrated in recent
NMR investigations of apocupredoxins [30]. Once formed, outer-sphere interactions lock
the active site in a geometry intermediate between that for CuII and CuI coordination.
Another feature of the binding site is the ability to accommodate other transition metal ions,
including CoII [31], NiII [32], ZnII [33], HgII [34], and AuI [35]. The CoII and NiII proteins
are redox-inactive within the aqueous window, but the structural features are similar to those
of the CuII proteins. Metrical parameters for several metal-substituted azurins as well as one
plastocyanin are given in Table 2. The bond lengths are all similar to those in Cu azurin,
albeit with shorter M-O(Gly45) and longer M-S(Cys112) bonds. Notably, HgII plastocyanin
shows an additional weak interaction with the backbone carbonyl of Pro46 that is absent in
the WT CuII protein, consistent with the ~0.3 Å difference in ionic radii of HgII and CuII.
4. Reduction Potentials
Many small molecule BCP-mimics fall short of reproducing T1 structure, spectroscopy and
reactivity [1,7,36-40]. It has been found that, in general, ligand sets that constrain complexes
to (pseudo)tetrahedral symmetry raise reduction potentials, presumably owing to weak
ligand fields. A few generalizations can be distilled [41] from the many factors that
influence the reduction potentials of protein embedded metal ions [42,43]. Since nonpolar
protein cavities disfavor charged species (as in organic solvents), the T1 [Cu-Cys]+ state is
disfavored and CuII/I reduction potentials (Table 1) are higher than that of aquo CuII (E°
(CuII/I) = 0.161 V [5]). Residues near T1 Cu also can modulate reduction potentials. To cite
one example, the surface proximal to T1 Cu in rusticyanin is hydrophobic/neutral, while the
analogous region of azurin is more hydrophobic/negatively charged, thereby accounting for
the relatively high rusticyanin CuII/I potential [44]. Mutations that delete or introduce
charged surface residues can substantially alter reduction potentials, as discussed below for
azurin.
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Reduction potentials for several BCPs are given in Table 3 [45-52]. Many of these reduction
potentials have been obtained by several different methods, including solution redox
titrations, optically transparent thin layer electrochemistry (OTTLE) and direct
electrochemistry. The potentials in Table 3 are “best values” and in our view are accurate to
±10 mV. These BCPs exhibit a 0.5 V range in CuII/I potentials, which is remarkable given
the similarities in inner-sphere coordination and protein tertiary structure. Also, most BCPs
have pH dependent reduction potentials, thereby indicating that reduction/oxidation is
coupled to protonation/deprotonation of a residue near the Cu center, though the exact origin
of the pH dependence is not always clear.
5. Inner-Sphere Effects on Blue Copper Properties
The spectroscopic and redox properties of BCPs depend strongly on the geometrical
arrangement of ligands around the Cu center, which is intermediate between the preferences
for CuII and CuI. Positioning the ligands in such a manner incurs some energetic penalty; as
the active site is in an activated or “entatic” state [53,54]. This energetic cost is overcome in
the case of BCPs by outer-sphere interactions between the Cu-ligating amino acids and
surrounding residues [55]. These networks, including H-bonding interactions, have been
referred to as “the rack,” and as such the rack may be said to induce the entatic state [56],
which we will take up again below.
Many investigators have probed the effects of altering the primary coordination sphere in
BCPs. Substitution of Met121 in P. aeruginosa azurin with a hydrophobic residue without a
donor atom (Ala, Val, Leu, Ile) increases the CuII/I potential by 60-140 mV, while
substitution with Glu markedly lowers the potential (His, Lys and Asp variants show little
change) [45,57]. The single-pH measurements in the original report masked more complex
behavior is some variants. Later pH dependent spectroscopic studies of the Met121Glu
protein showed that Glu is probably not coordinated at pH 4 and the Cu has T1 character
[58]. Glu121, which is deprotonated at higher pH, coordinates to CuII, lowering the CuII/I
potential and imparting T2-character to CuII. Likewise, several studies of Met121His azurin
have shown that ligation of His121 is pH-dependent, strongly affecting the spectroscopic
properties of the CuII center. Studies of these proteins led to the proposal of “type 1.5” Cu,
which has features intermediate between those of T1 and T2 centers [59].
Met121Ala [60] and Met121Glu [61] variants have been structurally characterized (Figure
2). In the Met121Ala structure, the Cu-S(Cys112) bond contracts by 0.2 Å versus WT and
the Cu-N3(His) bonds are elongated by about 0.1 Å versus WT. The Cu-S(Cys112) bond
shows the same contraction in Met121Glu, while Cu-N3(His) is even more elongated and
there is a Cu-O(Glu121) interaction (2.17 Å). In comparison to WT azurin, the CuII ion
moves noticeably toward Glu121, while the rest of the ligating residues do not move. In the
Ala121 variant, the CuII moves little with respect to WT azurin, but the ligating residues are
displaced substantially based on an overlay of α-carbons. For reference, the RMS deviation
between the ligating residues in WT azurin and Met121Ala is 0.213 and between WT and
Met121Glu is 0.187.
Lu and coworkers extended Met121X mutations in azurin to include unnatural amino acids
that are roughly isostructural with Met [62,63]. A key result was that the CuII/I reduction
potentials, which vary from 0.220 to 0.450 V, scale linearly with the water/octanol partition
coefficient (log P); increasing hydrophobicity raises reduction potentials. Others have made
Met → X mutations in amicyanin [64], cucumber basic protein [65] and rusticyanin [66]
with similar results, confirming that variations in hydrophobicity affect BCP reduction
potentials. Likewise, in stellacyanin [67] and umecyanin [65], which have no natural Met
(see below), Gln → Met mutations increase reduction potentials.
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More recently, Lu and coworkers replaced Met121 with Cys or homocysteine (Hcy) [68]. At
low pH the Met121Cys variant exhibited many features of T1 Cu, while at high pH it
became a “green copper” center with blue shifted spectral features and somewhat larger A||.
The Met121Hcy derivative showed radically different spectroscopic features and a low
reduction potential, consistent with the T2, red CuII protein nitrosocyanin in which CuII is
ligated by 2 His residues, as well as by Cys, Asp and H2O in a nearly ideal trigonal
bipyramidal geometry [69,70].
The roles of the key His-His-Cys residues in BCPs also have been elucidated. Sulfur π(Cys)
→ Cu 3dx2–y2 LMCT is responsible for the blue color of these proteins as well as certain
other spectroscopic features [3]. Thus, it is not surprising that the Cys112Asp variant of
azurin is comparatively colorless [71]. Broad bands in the visible spectrum attributable to d-
d transitions appear near 15,000 cm-1 (ε ~ 100 M–1 cm–1) [71]. The EPR spectrum shows a
much larger A|| than WT azurin [71,72]. Both of these observations are consistent with
conversion from T1 to T2 Cu [3]. Cys112Asp E°’ is 0.180 V; and there are noticeable
geometry changes in the solid state [73].
The only other metalation-competent Cys112X azurin is the selenocysteine-substituted
variant [74], which has been extensively characterized using a host of spectroscopic
techniques [75,76]. The main band in the optical spectrum is red shifted to 14,700 cm–1 and
the EPR spectrum shows a 2-fold increase in A|| (to 310 MHz) versus WT azurin. The Cu-Se
bond is elongated compared to Cu-S in WT azurin as determined by K-edge EXAFS
(d(CuII-Se) = 2.30(2) Å) (EXAFS = extended X-ray absorption fine structure). Like WT
azurin, the Cu-Se bond undergoes little change upon reduction (d(CuI-Se) = 2.33(2) Å), in
further support of a rack-constrained coordination geometry [75].
Work from our laboratory has probed Met121X substitutions in the Cys112Asp scaffold
[72,77]. As with WT azurin, replacement of Met with hydrophobic or positively charged
residues raises the CuII/I reduction potential. Notably, the Met121Glu variant displays
anomalous behavior. Accompanying the raised E°’ values, replacement of Met121 with Leu
(Figure 3), Phe or Ile results in proteins whose features are not those of either T1 or T2 Cu.
The proteins lack intense charge transfer bands in the visible region and exhibit A|| near 300
MHz. Moreover, they exhibit a 100-fold increase in ET reactivity relative to a Cys112Asp
single mutant. We adopted the term “type zero” for this class of CuII proteins.
His117 is a key residue in ET reactions of azurin [78]. Canters and coworkers investigated
azurin variants where His117 is replaced with glycine [79,80], which creates a “hole” in the
azurin coordination sphere owing to a large rearrangement in the protein backbone [81]. The
unsaturated coordination sphere allows for addition of exogenous ligands including halides,
azide and imidazoles to the copper center. From UV-visible (UV-vis), Raman and EPR data
it was concluded that addition of imidazole “rescues” the T1 Cu center, while addition of
anionic ligands enhances T2-character [79]. The open coordination site also allows ET and
structural investigations using imidazole-modified complexes [81,82,83].
His46 has been replaced with the other 19 amino acids [84]. All of the His46X variants were
expressed in E. coli based on Western blot analysis, but only His46Asp has been extensively
investigated. The CuII/I reduction potential (0.266 V, pH 7) and A|| (66 MHz) are
characteristic for BCPs, but shifted somewhat, reflecting the introduction of an anionic
aspartate ligand. NMR analysis suggests subtle structural changes to the Cu-binding pocket,
as well as decreased Cu-S(Cys112) and increased Cu-S(Met121) interactions [85].
Intramolecular ET reactions between CuI-His46Asp azurin and a surface tethered Ru-
oxidant are slower compared to those in WT azurin [86], owing to weaker electronic
coupling associated with the His to Asp mutation.
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Stellacyanin, and closely related protein, umecyanin [87], are unique among BCPs because
the WT proteins do not have active-site methionine residues. Stellacyanin has a relatively
low CuII/I reduction potential (Table 3) and its EPR spectrum is distinct from those of other
BCPs (it has substantial anisotropy in g⊥: gx = 2.018, gy = 2.077) [88]. X-ray structures of
the proteins showed that the axial ligand is the oxygen from a Gln amide (Gln99 in
stellacyanin and or Gln95 in umecyanin) [29,87]. Importantly, the Cu atom is displaced
below the His-His-Cys plane (toward Gln) by about 0.4 Å, making the geometry closer to
tetrahedral than trigonal planar. By analyzing several spectroscopic features of WT,
Gln99Met and Gln99Leu stellacyanin, DeBeer and coworkers showed that the axial ligand
modulates the Cu geometry and also the [Cu-SCys]+ covalency. They also concluded that
the lowering of the CuII/I reduction potential in stellacyanin is predominantly a result of
decreased active-site charge (Zeff, owing to the presence of Gln99). The Gln99Met mutation
produces a stellacyanin with spectroscopic and redox properties similar to those of
plastocyanin, as would be expected (both possess a His-His-Cys-Met ligand set).
pH can strongly affect coordination of the inner-sphere residues in BCPs. Guss and Freeman
first conclusively illustrated this property in the analysis of poplar plastocyanin crystallized
at 6 pH values [25]. The structure of the reduced proteins showed that the solvent exposed
His87, which moves away from CuI as the pH is lowered, is fully dissociated below pH 4.
Similarly, surface exposed His residues in related plastocyanins titrate with pKas between
4.5 and 5.5 [89-91]. Dissociation of the surface exposed His also occurs in CuI amicyanin
from two different sources, with pKa values between 7.2 and 7.5 [27,92]. In contrast, the
exposed His residues in azurin and rusticyanin remain coordinated to Cu across a wide range
of pH [21,23]. The variability of surface His pKas among BCPs likely is a result of very
different outer-sphere interactions in the vicinity of that residue. Finally, BCPs where the
exposed His is dissociated from Cu are less ET-active, probably because of their
unfavorable reduction potentials [27,89,92]. Such behavior could play a role in regulating
interprotein ET, as suggested for reaction of amicyanin with cytochrome c551 [27].
In sum, multiple studies have shown that the three strong ligands (His, His, Cys) in BCPs
are largely responsible for the bright blue color and small 63,65Cu hyperfine coupling of T1
Cu. Substitution of even one of those ligands typically results in dramatic electronic
structural changes. The one notable exception to this rule is His46Asp azurin. Axial ligand
substitution can strongly alter reduction potentials and (to a lesser extent) spectroscopic
properties.
6. Outer-Sphere Coordination
The key role of outer-sphere coordination in BCPs was widely appreciated in the early
1990s. Once x-ray structures of several BCPs were available (Figure 4) it became apparent
that residues not directly bound to the Cu center could affect spectroscopic and/or redox
properties [21,45]. In azurin, the Cys112 thiolate accepts hydrogen bonds (H-bonds) from
backbone amides of Asn47, and Phe114, and His46 donates a hydrogen bond to the
backbone carbonyl of Asn10. In rusticyanin, Cys138-S accepts H-bonds from backbone
amides of Ser86 and Ile140. Also, His85 donates an H-bond to the sidechain carbonyl of
Asn80. The Cys84 thiolate of plastocyanin accepts one H-bond from a backbone NH
(Asn38), and His37 interacts strongly with backbone carbonyls of Ala33, and more weakly
with the backbone carbonyls of Leu5, Gly 34, and the backbone amide NH of Phe35. In
amicyanin, the Cys92 thiolate weakly interacts (d(S-N) = 3.64 Å) with the backbone NH
from Asn54. His53 interacts with the backbone carbonyl of Met51, but also forms a strong
H-bond with the carboxylate of Glu49. The Cu-ligating Cys89 in stellacyanin accepts H-
bonds from the sidechain of Asn47 and the backbone amide NHs of Asn47, and Val91.
Notably, the NH2 group of the ligating Gln89 interacts with N3 of the ligated His46 and the
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indole NH of nearby Trp13. Finally, The Cu-ligating His imidazoles of cucumber basic
protein do not interact with the peptide, but the Cys79 thiolate weakly interacts with
backbone NHs of Asn40 and Phe81.
The above description is only part of the picture. Consider, for example, the H-bond network
that orients Cys112, His117 and Met121 around the copper center in azurin (Figure 5). This
network, which is coupled to other H-bonds that extend throughout much of the protein, is
thought to mediate long-range intramolecular ET [93,94].
In sum, T1 Cu centers display not only similar inner-sphere coordination, but also share
several common outer-sphere coordination motifs. The ligating Cys-thiolate accepts 1-2 H-
bonds from backbone carbonyls, modifying Cu-Cys covalency, and thus reduction
potentials. One of the ligating His residues donates an H-bond to a nearby backbone
carbonyl or another sidechain; this interaction could orient His around the metal center, or
could impart partial histidinate character to the ligand, stabilizing higher oxidation states as
in His-ligated peroxidases [17].
7. Outer-Sphere Effects on Blue Copper Properties
Perturbations to their outer coordination spheres can strongly affect the spectroscopic
properties and reactivities of BCPs. In early work, azurin ET self-exchange reactions were
shown to involve the hydrophobic patch near the H117-Cu site, as indicated by kinetics
study of Met44Lys and WT azurin [95]. It was found that mutation of the surface residue
Met64 to Glu decreases the rate constant by 102-fold when Glu is deprotonated [96]. The
spectroscopic features of the Met64Glu variant resemble WT, while the reduction potential
drops by ca. 25 mV. The lowered reduction potential likely results from electrostatic
stabilization of CuII by the additional negative charge at the protein surface. Likewise, the
Met64Lys mutation slows the self-exchange reaction and raises the reduction potential [95].
Phe114 is another key residue in the hydrophobic patch of azurin; its replacement affects the
spectroscopic and structural features of the Cu center. The Phe114Ala and Phe114Val
variants show distortions in Cu coordination, but only small changes in spectroscopic
features [97]. The amide NH of Phe114 forms an H-bond with the Cys112 thiolate, so the
structural changes probably are related to the additional conformational freedom when Ala
or Val occupy position 114.
Dennison and coworkers have produced a Phe114Pro azurin variant, a mutation that
eliminates the amide-Cys hydrogen bond entirely [98]. Like the Phe114Val and Phe114Ala
variants, this mutation substantially changes how the backbone interacts with the ligating
Cys112. Unlike WT azurin, the Cu atom position and Cu-L bond lengths change
significantly (≥ 0.1Å) upon cycling between CuI and CuII. In the CuII mutant, the
characteristic ~16,000 cm–1 band blue shifts by ~800 cm–1, and the CuII/I reduction potential
is 90 mV lower than the WT protein. Removal of the Phe114-NH···Cys112 H-bond results
in rotation of the Cu-Cys dihedral (7° in WT azurin and 34° in Phe114Pro azurin), while Cu
moves away from Gly45 and toward Met121. In short, removal of one H-bond from the
backbone to the Cys112 thiolate causes substantial changes in Cu coordination.
Dennison and coworkers also have systematically investigated the role of the loop region
between Cys112 and Met121 on BCP properties [99-101]. Interestingly, changing the native
azurin loop sequence (C112TFPGH117SALM121) to the shorter plastocyanin loop
(C112SPH115QGAGM120, azurin numbering) results in an azurin-like global fold, but
plastocyanin-like Cu properties (λmax, E°’, A||) [100]; and the same effect is found when the
azurin loop is replaced with that of amicyanin, or when the plastocyanin loop is replaced
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with that of azurin [99]. It is apparent that the loop region is a critical determinant of the
geometric arrangement of ligands around Cu, and thus the properties of the active site.
Type zero Cys112Asp/Met121X (X = Leu, Phe, Ile) azurins represent cases where the rack
controls electronic structure and reactivity. Removal of axial ligation from the Cys112Asp
framework drives CuII toward the Gly45 carbonyl, and rotation of the Asp112 carboxylate
attends this migration; in its resulting orientation, the coordination of this sidechain becomes
monodentate. The nondonating (to Cu) O is positioned to H-bond with Phe114 and Asn47,
restoring the rack. As in T1 Cu proteins, these H-bonds constrain CuII and CuI states to
similar geometries, lowering the ET reorganization energy [102]. Moreover, the electronic
structure undergoes a “coupled distortion” [103], where the singly occupied molecular
orbital rotates such that CuII experiences a dramatically weaker ligand field, thereby giving
rise to the Az values characteristic of type zero copper [104].
Our investigation of the Cys112Asp/Met121X azurin scaffold not only resulted in the
discovery of type zero copper, but also exposed subtler effects of outer-sphere coordination
that would have otherwise been masked by the dominant Cu-S(Cys) interaction. Of special
interest is Cys112Asp/Met121Glu, which has an anomalously high CuII/I reduction potential
(E°’ = 0.270 V, pH 7) that is pH dependent (pKa near 8). It is likely that the high potential is
attributable to the protonation of His35, which profoundly affects Cu coordination. At low
pH, His35 is protonated and clashes with the ligating His46, effectively pushing the Cu
away from Glu121, enforcing unfavorable three-coordination (Figure 6). At high pH, His35
is deprotonated, allowing Cu to “sink” toward Glu 121. The signature absorption in the
optical spectrum red shifts and A|| increases as the ligand field (LF) strength of the Cu center
increases. Commensurate with these changes, the E°’ plummets to 120 mV, an example
where steric clash, not H-bonding, exerts an outer-sphere effect. These seemingly subtle
structural changes result in drastic changes in the properties of the copper center and should
be considered in structural analyses of redox proteins.
Investigations of P. denitrificans amicyanin have shown that replacement of key surface
residues distal to the Cu atom can result in changes in ET reactivity most likely attributable
to perturbations to electrostatic interactions with redox partners [105]. Amicyanin is unusual
because in the solid state His95 is not ligated to CuI [27]; the solution pH dependence of E°
(CuII/I) tracks with protonation/deprotonation of this residue. Interestingly, the amicyanin
potential is shifted (E°’(CuII/I) = 0.22 V [106]) and pH independent in the presence of
cytochrome c551 [27]. It is thought that when complexed to a protein redox partner, His95
must be (at least partially) coordinated to CuI due to steric clash with residues in the other
protein. Conformational specificity is also though to play a role in rapid ET between azurin
and cytochrome c551 [107]. It is possible that these types of protein-protein outer-sphere
interactions play critical roles in redox function, as in the reactions of ribonucleotide
reductases [108].
Replacement of amicyanin Pro94 with Ala or Phe results in substantial changes in CuII/I
reduction potentials, as well as absorption red shifting (16,700 to 16,400 cm–1) and
increasing A|| (222 to 285 MHz). These mutations also strongly affect the pH dependence of
the CuII/I reduction potential [109], which could be understood when x-ray structures
became available [110]. Replacement of Pro94 allows a backbone amide NH to donate an
H-bond to the Cys92 thiolate, making the [Cu-S]+ less electron rich and easier to reduce.
Interestingly, His95 remains ligated to CuI in the solid state, perhaps because the pKa shift
induced by the mutation to Pro94 disfavors protonation of His95 [109]. Analysis of x-ray
structures showed that Phe94 is oriented “in” toward the body of the protein, thereby
causing steric clash and rearrangement of Met71; the backbone around Phe94/His95/Pro96
also shifts, promoting a conformation that pushes His95 toward Cu. Notably, the shift from
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0.385 (Pro94Ala) to 0.415 V (Pro94Phe) is consistent with azurin work that showed that
introduction of Phe residues near the Cu center increases E°’(CuII/I) by about 30 mV per Phe
[111].
In related work on plastocyanin, Spiro and coworkers found that replacement of
plastocyanin Asn38 with Gln, Thr or Leu produced a protein that would irreversibly lose Cu
over time [112]. While the position 38 mutants were not structurally characterized, it is
known from the WT structure that the Asn38 amide NH H-bonds to the Cys84 thiolate.
Also, the terminal amide of Asn38 H-bonds with Ser85, which could contribute to T1 Cu
site stability. Spiro concluded that these outer-sphere interactions protect the T1 sites from
misligation and Cys84 from oxidation.
8. Concluding Remarks
Great strides have been made in understanding the remarkable properties of T1 Cu centers.
We now know that it is not only the primary coordination sphere that modulates the CuII/I
reduction potential and spectroscopic features, but key contributions also come from the
interplay between the Cu ligands and the surrounding protein matrix. The three strong
ligands (His-His-Cys) are necessary for blue copper features, as replacement of even one of
these ligands produces nonblue properties. In some cases T1 Cu can be rescued by
exogenous ligands, or new behavior (type zero) can be introduced with additional mutations.
We also have highlighted a set of common features for outer-sphere coordination in blue
copper [11]. First, the ligating Cys thiolate accepts H-bonds from backbone amides,
contributing to changes in T1 Cu-Cys covalency. In most BCPs one of the ligating His
residues donates H-bonds to backbone carbonyls or other sidechains. These interactions may
orient the His or impart histidinate character on this ligating residue, as has been suggested
in studies of CueO [113] and Fet3p [114]. Abolishing histidinate-promoting interactions by
changing outer-sphere ligands destabilizes CuII, raising the CuII/I reduction potential.
Beyond these outer-sphere interactions are extensive H-bond networks throughout the
protein. Some of these interactions are part of the rack that defines the spectral features and
ET reactivities of T1 sites.
In sum, studies of blue copper proteins have elucidated many of the features that tune
reduction potentials and promote redox reactions. It is of interest that Lu and coworkers
rationally designed azurins with reduction potentials that span a 700 mV range using only a
handful of inner- and outer-sphere mutations [115]. Related investigations of metal
coordination in proteins have the potential to yield artificial enzymes for catalysis of very
challenging chemical transformations.
Acknowledgments
Our work is supported by NIH (DK019038 to HBG) and (GM095037 to JJW). We are grateful to Alejandro Vila
for a preprint of reference 30.
References
1. Dennison C. Coord. Chem. Rev. 2005; 249:3025–3054.
2. Gray HB, Malmström BG, Williams RJP. J. Biol. Inorg. Chem. 2000; 5:551–559. [PubMed:
11085645]
3. Solomon EI, Baldwin MJ, Lowery MD. Chem. Rev. 1992; 92:521–542.
4. Solomon EI, Szilagyi RK, DeBeer George S, Basumallick L. Chem. Rev. 2004; 104:419–458.
[PubMed: 14871131]
5. Bratsch SG. J. Phys. Chem. Ref. Data. 1989; 18:1–21.
Warren et al. Page 9
J Inorg Biochem. Author manuscript; available in PMC 2013 October 01.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
6. Lever ABP. Inorg. Chem. 1990; 29:1271–1285.
7. James BR, Williams RJP. J. Chem. Soc. 1961:2007–2019.
8. Yokoi H, Addison AW. Inorg. Chem. 1977; 16:1341–1349.
9. Sakaguchi U, Addison AW. J. Chem. Soc., Dalton Trans. 1979:600–608.
10. Dockal ER, Jones TE, Sokol WF, Engerer RJ, Rorabacher DB, Ochrymowycz LA. J. Am. Chem.
Soc. 1976; 98:4322–4324. [PubMed: 932364]
11. Lancaster KM. Struct. Bond. 2012; 142:119–153.
12. Werner, A. Neuere anschauungen auf dem gebiete der anorganischen chemie. 3rd ed.. Vieweg und
Sohn; Braunschweig: 1913.
13. Yikilmaz E, Porta J, Grove LE, Vahedi-Faridi A, Bronshteyn Y, Brunold TC, Borgstahl GEO,
Miller A-F. J. Am. Chem. Soc. 2007; 129:9927–9940. [PubMed: 17628062]
14. Grove LE, Brunold TC. Comm. Inorg. Chem. 2008; 29:134–168.
15. Grove LE, Xie J, Yikilmaz E, Miller A-F, Brunold TC. Inorg. Chem. 2008; 47:3978–3992.
[PubMed: 18433120]
16. Springer BA, Sligar SG, Olson JS, Phillips GN Jr. Chem. Rev. 1994; 94:699–714.
17. Dunford, HB. Peroxidases and Catalases. John Wiley and Sons; Hoboken: 2010.
18. Chapman GV, Colman PM, Freeman HC, Guss JM, Mitsuo M, Norris VA, Ramshaw JAM,
Venkatappa MP. J. Mol. Biol. 1977; 110:187–189. [PubMed: 845945]
19. Colman PM, Freeman HC, Guss JM, Murata M, Norris VA, Ramshaw JAM, Venkatappa MP.
Nature. 1978; 272:319–324.
20. [23 February 2012] http://www.rcsb.org/pdb/static.do?p=general_information/pdb_statistics/
index.html
21. Nar H, Messerschmidt A, Huber R, van, Mart d. K. Canters GW. J. Mol. Biol. 1991; 221:765–772.
[PubMed: 1942029]
22. Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE.
Nucleic Acids Res. 2000; 28:235–242. http:www.pdb.org. [PubMed: 10592235]
23. Walter RL, Ealick SE, Friedman AM, Blake RC II, Proctor P, Shoham M. J. Mol. Biol. 1996;
263:730–751. [PubMed: 8947572]
24. Guss JM, Bartunik HD, Freeman HC. Acta Cryst. B. 1992; 48:790–811. [PubMed: 1492962]
25. Guss JM, Harrowell PR, Murata M, Norris VA, Freeman HC. J. Mol. Biol. 1986; 192:361–387.
[PubMed: 3560221]
26. Cunane LM, Chen Z-W, Durley RCE, Mathews FS. Acta Cryst. D. 1996; 52:676–686. [PubMed:
15299631]
27. Zhu Z, Cunane LM, Chen Z-W, Durley RCE, Mathews FS, Davidson VL. Biochemistry. 1998;
37:17128–17136. [PubMed: 9860825]
28. Guss JM, Merritt EA, Phizackerley RP, Freeman HC. J. Mol. Biol. 1996; 262:686–705. [PubMed:
8876647]
29. Hart PJ, Eisenberg D, Nersissian AM, Valentine JS, Herrmann RG, Nalbandyan RM. Protein Sci.
1996; 5:2175–2183. [PubMed: 8931136]
30. Zaballa M-E, Abriata LA, Donnaire A, Vila AJ. Proc. Natl. Acad. Sci. U.S.A. 2012 Accepted for
publication.
31. Bonander N, Vänngård T, Tsai L-C, Langer V, Nar H, Sjölin L. Proteins. 1997; 27:385–394.
[PubMed: 9094740]
32. Tsai L-C, Sjölin L, Langer V, Bonander N, Karlsson BG, Vänngård T, Hammann C, Nar H. Acta
Cryst. D. 1995; 51:711–717. [PubMed: 15299800]
33. Nar H, Huber R, Messerschmidt A, Filippou AC, Barth M, Jaquinod M, van de Kamp M, Canters
GW. Eur. J. Biochem. 1992; 205:1123–1129. [PubMed: 1576995]
34. Church WB, Guss JM, Potter JJ, Freeman HC. J. Biol. Chem. 1986; 261:234–237. [PubMed:
3941073]
35. McCleskey TM, Mizoguchi TJ, Richards JH, Gray HB. Inorg. Chem. 1996; 35:3434–3435.
[PubMed: 11666550]
36. Kitajima N, Fujisawa K, Morooka Y. J. Am. Chem. Soc. 1990; 112:3210–3212.
Warren et al. Page 10
J Inorg Biochem. Author manuscript; available in PMC 2013 October 01.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
37. Kitajima N, Fujisawa K, Tanaka M, Morooka Y. J. Am. Chem. Soc. 1992; 114:9232–9233.
38. Holland PL, Tolman WB. J. Am. Chem. Soc. 1999; 121:7270–7271.
39. Holland PL, Tolman WB. J. Am. Chem. Soc. 2000; 122:6331–6332.e Yang L, Tolman W. J. Biol.
Inorg. Chem. 2012; 17:285–291. [PubMed: 21960257]
40. Yang L, Tolman W. J. Biol. Inorg. Chem. 2012; 17:285–291. [PubMed: 21960257]
41. Rees DC. Proc. Natl. Acad. Sci. U.S.A. 1985; 82:3082–3085. [PubMed: 3858805]
42. Moore GR, Pettigrew GW, Rogers NK. Proc. Natl. Acad. Sci. U.S.A. 1986; 83:4998–4999.
[PubMed: 3460080]
43. Tezcan FA, Winkler JR, Gray HB. J. Am. Chem. Soc. 1998; 120:13383–13388.
44. Botuyan MV, Toy-Palmer A, Chung J, Blake II, Robert C, Beroza P, Case DA, Dyson HJ. J. Mol.
Biol. 1996; 263:752–767. [PubMed: 8947573]
45. Pascher T, Karsson BG, Nordling M, Malmström BG, Vänngård T. Eur. J. Biochem. 1993;
212:289–296. [PubMed: 8383044]
46. Sigfridsson K, Young S, Hansson Ö. Biochemistry. 1996; 35:1249–1257. [PubMed: 8573580]
47. Niles M, Dharmini D, Freeman HC, Harvey I, Lay PA, Bond AM. Inorg. Chem. 1996; 35:7156–
7165. [PubMed: 11666900]
48. Blake RC, White KJ, Shute EA. Biochemistry. 1991; 30:9443–9449. [PubMed: 1892845]
49. Gray KA, Knaff DB, Husain M, Davidson VL. FEBS Lett. 1986; 207:239–242. [PubMed:
3021532]
50. Nersissian AM, Valentine JS, Immoos C, Hill MG, Hart PJ, Williams G, Herrmann RG. Protein
Sci. 1998; 7:1915–1929. [PubMed: 9761472]
51. Reinhammar BRM. Biochim. Biophys. Acta. 1972; 275:245–259. [PubMed: 4342730]
52. Battistuzzi G, Borsari M, Loschi L, Sola M. J. Biol. Inorg. Chem. 1997; 2:350–359.
53. Lumry R, Eyring H. J. Phys. Chem. 1954; 58:110–120.
54. Vallee BL, Williams RJP. Proc. Natl. Acad. Sci. U.S.A. 1968; 59:498–505. [PubMed: 5238980]
55. Ghosh S, Xie X, Dey A, Sun Y, Scholes CP, Solomon EI. Proc. Natl. Acad. Sci. U.S.A. 2009;
106:4969–4974. [PubMed: 19282479]
56. Malmström BG. Eur. J. Biochem. 1994; 223:711–718. [PubMed: 8055947]
57. Karlsson BG, Nordling M, Pascher T, Tsai LC, Sjölin L, Lundberg LG. Protein Eng. 1991; 4:343–
349. [PubMed: 1649999]
58. Strange RW, Murphy LM, Karlsson BG, Reinhammar B, Hasnain SS. Biochemistry. 1996;
35:16391–16398. [PubMed: 8973215]
59. Kroes SJ, Hoitink CWG, Andrew CR, Ai J, Sanders-Loehr J, Messerschmidt A, Hagen WR,
Canters GW. Eur. J. Biochem. 1996; 240:342–351. [PubMed: 8841397]
60. Tsai L-C, Bonander N, Harata K, Karlsson G, Vänngård T, Langer V, Sjölin L. Acta Cryst. D.
1996; 52:950–958. [PubMed: 15299604]
61. Karlsson BG, Tsai L-C, Nar H, Sanders-Loehr J, Bonander N, Langer V, Sjölin L. Biochemistry.
1997; 36:4089–4095. [PubMed: 9100002]
62. Berry SM, Ralle M, Low DW, Blackburn NJ, Lu Y. J. Am. Chem. Soc. 2003; 125:8760–8768.
[PubMed: 12862470]
63. Garner DK, Vaughan MD, Hwang HJ, Savelieff MG, Berry SM, Honek JF, Lu Y. J. Am. Chem.
Soc. 2006; 128:15608–15617. [PubMed: 17147368]
64. Diederix REM, Canters GW, Dennison C. Biochemistry. 2000; 39:9551–9560. [PubMed:
10924152]
65. Yanagisawa S, Dennison C. J. Am. Chem. Soc. 2005; 127:16453–16459. [PubMed: 16305231]
66. Hall JF, Kanbi LD, Strange RW, Hasnain SS. Biochemistry. 1999; 38:12675–12680. [PubMed:
10504237]
67. DeBeer George S, Basumallick L, Szilagyi RK, Randall DW, Hill MG, Nersissian AM, Valentine
JS, Hedman B, Hodgson KO, Solomon EI. J. Am. Chem. Soc. 2003; 125:11314–11328. [PubMed:
16220954]
68. Clark KM, Yu Y, Marshall NM, Sieracki NA, Nilges MJ, Blackburn NJ, van der Donk WA, Lu Y.
J. Am. Chem. Soc. 2010; 132:10093–10101. [PubMed: 20608676]
Warren et al. Page 11
J Inorg Biochem. Author manuscript; available in PMC 2013 October 01.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
69. Whittaker M, Bergmann D, Arciero D, Hooper AB. Biochim. Biophys. Acta. 2000; 1459:346–355.
[PubMed: 11004450]
70. Lieberman RL, Arciero DM, Hooper AB, Rosenzweig AC. Biochemistry. 2001; 40:5674–5681.
[PubMed: 11341832]
71. Mizoguchi TJ, Di Bilio AJ, Gray HB, Richards JH. J. Am. Chem. Soc. 1992; 114:10076–10078.
72. Lancaster KM, Yokoyama K, Richards JH, Winkler JR, Gray HB. Inorg. Chem. 2008; 48:1278–
1280. [PubMed: 19113863]
73. Faham S, Mizoguchi TJ, Adman ET, Gray HB, Richards JH, Rees DC. J. Biol. Inorg. Chem. 1997;
2:464–469.
74. Berry SM, Gieselman MD, Nilges MJ, van der Donk WA, Lu Y. J. Am. Chem. Soc. 2002;
124:2084–2085. [PubMed: 11878940]
75. Ralle M, Berry SM, Nilges MJ, Gieselman MD, van, Wilfred A. d. D. Lu Y, Blackburn NJ. J. Am.
Chem. Soc. 2004; 126:7244–7256. [PubMed: 15186162]
76. Sarangi R, Gorelsky SI, Basumallick L, Hwang HJ, Pratt RC, Stack TDP, Lu Y, Hodgson KO,
Hedman B, Solomon EI. J. Am. Chem. Soc. 2008; 130:3866–3877. [PubMed: 18314977]
77. Lancaster KM, George SD, Yokoyama K, Richards JH, Gray HB. Nat. Chem. 2009; 1:711–715.
[PubMed: 20305734]
78. Jeuken LJC, van, Pieter V, Verbeet MP, Camba R, McEvoy JP, Armstrong FA, Canters GW. J.
Am. Chem. Soc. 2000; 122:12186–12194.
79. den Blaauwen T, Canters GW. J. Am. Chem. Soc. 1993; 115:1121–1129.
80. den, Tanneke B, Hoitink CWG, Canters GW, Han J, Loehr TM, Sanders-Loehr J. Biochemistry.
1993; 32:12455–12464. [PubMed: 8241136]
81. Alagaratnam S, Meeuwenoord NJ, Navarro JA, Hervás M, De la Rosa MA, Hoffmann M, Einsle
O, Ubbink M, Canters GW. FEBS J. 2011; 278:1506–1521. [PubMed: 21352498]
82. Gorren ACF, den, Tanneke B, Canters GW, Hopper DJ, Duine JA. FEBS Letters. 1996; 381:140–
142. [PubMed: 8641423]
83. de Jongh TE, van, Anne-Marie M. R, Prudencio M, Ubbink M, Canters GW. Eur. J. Inorg. Chem.
2006; 2006:3861–3868.
84. Germanas JP, Di, Angel J. B, Gray HB, Richards JH. Biochemistry. 1993; 32:7698–7702.
[PubMed: 8394112]
85. Vila AJ, Ramirez BE, Di, A. J. B, Mizoguchi TJ, Richards JH, Gray HB. Inorg. Chem. 1997;
36:4567–4570. [PubMed: 11670122]
86. Regan JJ, Di, A.J. B, Winkler JR, Richards JH, Gray HB. Inorg. Chim. Acta. 1998; 275:470–480.
87. Koch M, Velarde M, Harrison MD, Echt S, Fischer M, Messerschmidt A, Dennison C. J. Am.
Chem. Soc. 2004; 127:158–166. [PubMed: 15631465]
88. Gewirth AA, Cohen SL, Schugar HJ, Solomon EI. Inorg. Chem. 1987; 26:1133–1146.
89. Wu Q, Li F, Wang W, Hecht MH, Spiro TG. J. Inorg. Biochem. 2002; 88:381–387. [PubMed:
11897354]
90. Jackman MP, Sinclair-Day JD, Sisley MJ, Sykes AG, Denys LA, Wright PE. J. Am. Chem. Soc.
1987; 109:6443–6449.
91. Hulsker R, Mery A, Thomassen EA, Ranieri A, Sola M, Verbeet MP, Kohzuma T, Ubbink M. J.
Am. Chem. Soc. 2007; 129:4423–4429. [PubMed: 17367139]
92. Lommen A, Canters GW. J. Biol. Chem. 1990; 265:2768–2774. [PubMed: 2303425]
93. Farver O, Pecht I. J. Am. Chem. Soc. 1992; 114:5764–5767.
94. Farver O, Pecht I. J. Biol. Inorg. Chem. 1997; 2:387–392.
95. van de Kamp M, Floris R, Hali FC, Canters GW. J. Am. Chem. Soc. 1990; 112:907–908.
96. van Pouderoyen G, Mazumdar S, Hunt NI, Hill HAO, Canters GW. Eur. J. Biochem. 1994;
222:583–588. [PubMed: 8020495]
97. Tsai L-C, Sjölin T, Langer V, Pascher T, Nar H. Acta Cryst. D. 1995; 51:168–176. [PubMed:
15299318]
98. Yanagisawa S, Banfield MJ, Dennison C. Biochemistry. 2006; 45:8812–8822. [PubMed:
16846224]
Warren et al. Page 12
J Inorg Biochem. Author manuscript; available in PMC 2013 October 01.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
99. Li C, Yanagisawa S, Martins BM, Messerschmidt A, Banfield MJ, Dennison C. Proc. Natl. Acad.
Sci. U.S.A. 2006; 103:7258–7263. [PubMed: 16651527]
100. Li C, Banfield MJ, Dennison C. J. Am. Chem. Soc. 2007; 129:709–718. [PubMed: 17227035]
101. Li C, Sato K, Monari S, Salard I, Sola M, Banfield MJ, Dennison C. Inorg. Chem. 2010; 50:482–
488.
102. Lancaster KM, Farver O, Wherland S, Crane EJ, Richards JH, Pecht I, Gray HB. J. Am. Chem.
Soc. 2011; 133:4865–4873. [PubMed: 21405124]
103. LaCroix LB, Shadle SE, Wang Y, Averill BA, Hedman B, Hodgson KO, Solomon EI. J. Am.
Chem. Soc. 1996; 118:7755–7768.
104. Lancaster KM, Zaballa M-E, Sproules S, Sundararajan M, DeBeer S, Richards JH, Vila AJ,
Neese F, Gray HB. J. Am Chem. Soc. 2012 Accepted for publication.
105. Ma JK, Wang Y, Carrell CJ, Mathews FS, Davidson VL. Biochemistry. 2007; 46:11137–11146.
[PubMed: 17824674]
106. Gray KA, Davidson VL, Knaff DB. J. Biol. Inorg. Chem. 1988; 263:13987–13990.
107. Rosen P, Pecht I. Biochemistry. 1976; 15:775–786. [PubMed: 174718]
108. Yokoyama K, Uhlin U, Stubbe J. J. Am. Chem. Soc. 2010; 132:15368–15379. [PubMed:
20929229]
109. Machczynski MC, Gray HB, Richards JH. J. Inorg. Biochem. 2002; 88:375–380. [PubMed:
11897353]
110. Carrell CJ, Sun D, Jiang S, Davidson VL, Mathews FS. Biochemistry. 2004; 43:9372–9380.
[PubMed: 15260480]
111. Berry SM, Baker MH, Reardon NJ. J. Inorg. Biochem. 2010; 104:1071–1078. [PubMed:
20615551]
112. Dong S, Ybe JA, Hecht MH, Spiro TG. Biochemistry. 1999; 38:3379–3385. [PubMed: 10079082]
113. Kataoka K, Hirota S, Maeda Y, Kogi H, Shinohara N, Sekimoto M, Sakurai T. Biochemistry.
2010; 50:558–565. [PubMed: 21142169]
114. Stoj CS, Augustine AJ, Zeigler L, Solomon EI, Kosman DJ. Biochemistry. 2006; 45:12741–
12749. [PubMed: 17042492]
115. Marshall NM, Garner DK, Wilson TD, Gao Y-G, Robinson H, Nilges MJ, Lu Y. Nature. 2009;
462:113–116. [PubMed: 19890331]
Warren et al. Page 13
J Inorg Biochem. Author manuscript; available in PMC 2013 October 01.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Highlights
• We present a focused review of metal coordination in blue copper proteins.
• Inner- and outer-sphere interactions tune properties of copper sites.
• Electronic structure and chemical reactivity of blue copper centers are
discussed.
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Figure 1.
Copper coordination in representative blue copper proteins in their oxidized forms. (A) P.
aeruginosa azurin; (B) T. ferrooxidans rusticyanin; (C) P. nigra plastocyanin; (D) P.
denitrificans amicyanin; (E) C. sativus cumber basic protein; (F) C. sativus stellacyanin.
Spheres indicate carbon (green), oxygen (red), nitrogen (blue) and copper (tan). The protein
tertiary structure is shown as a partially transparent grey ribbon.
Warren et al. Page 15
J Inorg Biochem. Author manuscript; available in PMC 2013 October 01.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Figure 2.
Comparison of Met121Glu (A) and Met121Ala (B) with the structure of WT P. aeruginosa
azurin. The WT structure is shown in white and is partially transparent. Spheres indicate
carbon (green), oxygen (red), nitrogen (blue) and copper (tan). The protein tertiary structure
is shown as a partially transparent grey or green ribbon.
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Figure 3.
X-ray structure of Cys112Asp/Met121Leu (type zero) azurin [77] (PDB ID 3FPY). Spheres
indicate carbon (green), oxygen (red), nitrogen (blue) and copper (tan). The protein tertiary
structure is shown as a partially transparent green ribbon. Cu-ligand distances (Å) are:
His46-N3 (1.94); His117-N3 (2.04); Asp112-O (1.92); Gly45-O (2.35) and Leu121-C
(3.84).
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Figure 4.
Outer-sphere coordination in representative blue copper proteins in their oxidized forms. (A)
P. aeruginosa azurin; (B) T. ferrooxidans rusticyanin; (C) P. nigra plastocyanin; (D) P.
denitrificans amicyanin; (E) C. sativus cumber basic protein; (F) C. sativus stellacyanin. Cu-
ligating residues are the same as in Figure 1.
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Figure 5.
View of the H-bond network surrounding Cu in P. aeruginosa azurin. Cu-ligating residues
are the same as in Figure 1.
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Figure 6.
Structural changes in Cys112Asp/Met121Glu P. aeruginosa azurin at pH 10 (green, solid)
and pH 7 (cyan, partially transparent). The PDB IDs are 3OQR and 3NP3, respectively.
Spheres indicate carbon (green/cyan), oxygen (red), nitrogen (blue) and copper (tan). The
protein tertiary structure is shown as a partially transparent grey ribbon.
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Table 3
CuII/I reduction potentials.
pH E°’ (V vs. NHE) Ref.
P. aeruginosa azurin 7.5 0.310 [45]
S. oleracea plastocyanin 7.5 0.384 [46]
P. nigra plastocyanin 7.5 0.380 [47]
T. ferrooxidans rusticyanin 2.0 0.680 [48]
P. denitrificans amicyanin 6.7 0.294 [49]
C. sativus stellacyanin 7.0 0.260 [50]
R. vernicifera stellacyanin 7.1 0.184 [51]
C. sativus cucumber basic protein 7.0 0.306 [52]
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